NCT04467593 - Safety Study of Whole Body Hyperthermia for Advanced Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

December 25, 2024

Study Completion Date

December 25, 2024

Conditions

Advanced CancerPancreatic Cancer Metastatic

Interventions

DEVICE

Whole body hyperthermia

Whole body hyperthermia to treat stage IV cancer patients

DRUG

Standard of Care (SOC) chemotherapy according to the NCCN guidelines.

Whole body hyperthermia to treat stage IV pancreatic cancer patients combined with standard of care chemotherapy

Trial Locations (1)

University Hospital Antwerp, Edegem